Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.35 → 3.38 EPS · FY ending Dec 31, 2027 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for RAL yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Complete $100 million accelerated share repurchase in 2026-Q1 | The company is buying back $100 million in shares, showing capital discipline. | Intact | ASR program is canceled or materially delayed | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth and efficiency story, with management aiming to expand margins while growing revenue. The long-term thesis is intact but on watch: guidance has risen and cost-saving plans are on track, while recent performance has been below its industry cohort.
Valuation is described as broadly aligned with expectations, with only a small premium versus peers and no major fragility signals. The expectations gap is close to neutral, so the evidence does not point to either unusually low expectations or strong optimism already priced in.
Near term, execution is supported by raised 2026 revenue and adjusted EBITDA margin guidance, alongside reported progress on savings and cash flow. Risk remains elevated: despite a recent earnings beat and low estimated miss risk, the snapshot notes recent misses and a downward trend in earnings surprises.
The multi-year thesis depends on delivering the planned annual savings and sustaining the higher guidance. A reversal and guidance cut would damage credibility; easier rates or steadier results from technology peers could improve the sector backdrop.
Over the next 1 to 3 years, RAL’s case is supported by growth, margin improvement, and capital returns, but recent performance and elevated risk leave execution as the key test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Ralliant Corp's published investment case. The stated target is >= $2.61. |
| Intact |
| EPS falls below $2.53 |
Diluted EPS: $0.77 per share FY2026-Q3; GAAP. Published target: >= $2.61. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 20260.77 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating margin near 20% in FY26 | A primary condition in Ralliant Corp's published investment case. The stated target is ~20%. | Intact | Operating margin falls below 19.5% | Operating margin: 18.95% FY2026-Q3; GAAP. Published target: ~20%. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 202618.948557 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Full-year 2026 revenue at or above $2.215 billion | A primary condition in Ralliant Corp's published investment case. The stated target is >= $2.215 billion. | Intact | Full-year revenue falls below $2.185 billion | Revenue: $620.1M FY2026-Q3; GAAP. Published target: >= $2.215 billion. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 2026620,100,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.09 → $3.38 · observed estimates
$2.37B → $2.46B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.09 | $2,366,421,110 | 12 / 12 |
| 2026-07-25 | $3.09 | $2,366,421,110 | 12 / 12 |
| 2026-07-26 | $3.09 | $2,366,421,110 | 12 / 12 |
| 2026-07-27 | $3.09 | $2,366,459,624 | 8 / 8 |
| 2026-07-28 | $3.09 | $2,366,421,110 | 12 / 12 |
| 2026-07-29 | $3.09 | $2,366,421,110 | 12 / 12 |
| 2026-07-30 | $3.09 | $2,366,421,110 | 12 / 12 |
| 2026-07-31 | $3.19 | $2,403,029,493 | 8 / 8 |
| 2026-08-01 | $3.19 | $2,403,029,493 | 8 / 8 |
| 2026-08-02 | $3.25 | $2,428,243,860 | 11 / 11 |
| 2026-08-03 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-04 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-05 | $3.28 | $2,436,243,860 | 11 / 11 |
| 2026-08-06 | $3.25 | $2,428,243,860 | 11 / 11 |
| 2026-08-07 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-08 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-09 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-10 | $3.28 | $2,436,243,860 | 11 / 11 |
| 2026-08-12 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-13 | $3.28 | $2,436,243,860 | 11 / 11 |
| 2026-08-14 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-15 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-16 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-17 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-18 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-19 | $3.25 | $2,428,246,439 | 8 / 8 |
| 2026-08-20 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-21 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-22 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-23 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-24 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-25 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-26 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-27 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-28 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-29 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-30 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-08-31 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-01 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-02 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-03 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-04 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-05 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-06 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-07 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-08 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-09 | $3.31 | $2,444,150,613 | 8 / 8 |
| 2026-09-10 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-11 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-12 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-13 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-14 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-15 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-16 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-17 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-18 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-19 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-20 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-21 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-22 | $3.33 | $2,447,468,795 | 8 / 8 |
| 2026-09-23 | $3.35 | $2,447,468,795 | 8 / 8 |
| 2026-09-24 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-09-25 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-09-26 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-09-27 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-09-28 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-09-29 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-09-30 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-01 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-02 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-03 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-04 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-05 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-06 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-07 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-08 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-09 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-10 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-11 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-12 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-13 | $3.35 | $2,447,468,795 | 7 / 8 |
| 2026-10-14 | $3.36 | $2,450,429,403 | 7 / 8 |
| 2026-10-15 | $3.38 | $2,457,702,131 | 7 / 8 |
| 2026-10-16 | $3.38 | $2,457,702,131 | 7 / 8 |
| 2026-10-17 | $3.38 | $2,457,702,131 | 7 / 8 |
| 2026-10-18 | $3.38 | $2,457,702,131 | 7 / 8 |
| 2026-10-19 | $3.38 | $2,457,702,131 | 7 / 8 |
| 2026-10-20 | $3.38 | $2,456,162,043 | 7 / 8 |
| 2026-10-21 | $3.38 | $2,456,162,043 | 7 / 8 |
| 2026-10-22 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-23 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-24 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-25 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-26 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-27 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-28 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-29 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-30 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-10-31 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-11-01 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-11-02 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-11-03 | $3.38 | $2,456,126,569 | 7 / 8 |
| 2026-11-04 | $3.38 | $2,456,126,569 | 7 / 8 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 3 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.